Editorial & Publishing Policies

Aim and Scope

The overall purpose of the European Clinical Respiratory Journal is to be a forum for the presentation of clinical and experimental studies, case reports, expert opinions and reviews within the area of respiratory diseases in children, adults and the elderly. 

According to a recent annual report of the World Health Organization (WHO), respiratory disease including lower respiratory infections, COPD and lung cancers accounted for the death of 7 million people worldwide. Presently, several hundreds of millions are suffering of chronic respiratory diseases imposing a large burden on both the society and healthcare.

Apart from genetic factors, the increasing number of patients with respiratory disorders is a direct result of exposure to pollutants and irritants, i.e., environmental factors, which present a major challenge for our immune defense system.  Research into the immunology and pathophysiology of the respiratory system will enable us to understand disease mechanisms and provide a broader understanding on how the body combats these diseases. 

The ERCJ accepts original articles, short communications and reviews under two sections:

1.      Scientific section

  • Epidemiology of disease
  • Preventive strategies
  • Pathophysiological and immunological mechanisms of respiratory diseases
  • Identification of potential future treatment targets and novel treatments of respiratory diseases
  • Clinical trials including randomized, placebo controlled and observational “real life” clinical trials
  • Clinical aspects of respiratory disease including systemic involvement and comorbidities
  • Improved diagnostic and research methods, including imaging techniques, physiological tests, sampling techniques and biomarkers
  • Occupational and environment related lung disease
  • Progress in smoking intervention and cessation methods
  • Disease and management-related issues, including self-management
  • Respiratory intensive and critical care
  • Updates on the status of and advances in specific disease areas, including allergy, asthma, ARDS, COPD, ILD, Cystic Fibrosis, bronchiectasis, respiratory infectious diseases, tuberculosis, lung cancer, and sleep-disordered breathing morbidity

2.      Educational section

The journal will also publish papers related to education activities aimed to translate basic scientific data into clinical relevant recommendations, including:

  • Treatment guidelines overview
  • Diagnostic procedures and recommendations
  • Literature reviews and meta-analyses
  • Case presentations and reviews of the literature
  • Letter to the editor
  • Expert opinions
  • Expert meetings and symposium proceedings

 

Section Policies

Editorials

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Invited Editorials

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Review Articles

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Invited Review Articles

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Original Research Articles

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Invited Original Research Articles

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Short Communications

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Letters to the Editor

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Case Reports

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

PhD Reviews

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Abstracts/Conference proceedings

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

VI Scandinavian COPD Research Symposium

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Supplement 1 2015

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Supplement 2016

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

Papers submitted to the European Clinical Respiratory Journal are subject to rigorous peer review.

All articles go through a preliminary review by the Chief Editor. Articles that are felt to be appropriate for full review are then assigned to a Section Editor who carries through the entire peer review process up to acceptance or rejection of the paper. All papers are reviewed by at least two independent referees.

Manuscripts are sent out for review electronically, and all correspondence takes place via e-mail.

The European Clinical Respiratory Journal has a 'double blind' review process: Authors are not told who reviewed their paper, and reviewers are not told who wrote the paper. Peer reviewers are informed of the identity of the authors immediately after the manuscript is either accepted or rejected. The referees’ identity remains unknown to the authors although it is up to the referee if he/she wants to contact the author at a later stage and reveal his/her identity. Peer reviewers are asked to give their opinion on a number of issues pertinent to the scientific and formal aspects of a paper, and to judge the papers on grounds of originality and urgency. All relevant information will be forwarded to the author(s).

Peer reviewers will have six possible options, for each article:

1. Accept manuscript (i.e. no need for any revision)
2. Accept after revision (i.e. accepted if the author makes the requested revisions)
3. Revise and resubmit (i.e. accepted or rejected after revisions have been made - paper will be sent out for another peer review round
4. Submit elsewhere (i.e. if the manuscript is better suited for another journal)
5. Reject manuscript (i.e. if the manuscript is substandard)
6. See comments (i.e. if the reviewer cannot choose from any of the above)

In addition, papers may be rejected directly by the Chief Editor if judged to be out of scope or if scientifically or formally sub-standard.

When asking for revisions, reviewers have two possible goals: to ask authors to tighten their arguments based on existing data or to identify areas where more data are needed. Even formal revision may be required if the language or style is sub-standard. To facilitate rapid publication, authors are given a maximum of 2 months for revision. After 2 months, revised manuscripts will be considered new submissions.

 

 

Publication Frequency

All articles are posted online immediately they are ready for publication. All articles will be assigned a DOI number (Digital Object Identifier) whereby it becomes possible to search and cite them without delay.

 

Open Access Policy

The European Clinical Respiratory Journal is published Open Access under a  Creative Commons CC-BY 4.0 license. Authors retain full copyright to their work. See copyright section.

Articles are published immediately upon the final corrections of the master proof having been made. All articles are assigned a DOI number (Digital Object Identifier). 

The European Clinical Respiratory Journal is accessible via the journal’s website as well as via international search engines such as Google and Google Scholar.

OAI metadata harvesting for this journal can be reached via the following link:

http://www.ecrj.net/index.php/ecrj/oai

 

 

Archiving

This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration.

In addition, all files will be archived with CLOCKSS and Portico.

 

Author Self-Archiving

Authors are permitted and encouraged to post any version of their manuscript to personal or institutional websites, in repositories and similar, prior to and after publication (while providing the bibliographic details of that publication).